Who
Arnold J. Levine
Director
Company insider
Files Form 4 as: Director, PMV Pharmaceuticals; Director, MeiraGTx Holdings; Director, Innoviva; Director, Life Technologies; Director, Infinity Pharmaceuticals; Director, Applied Biosystems.
In numbers
- Trades disclosed
- 124
- Buys
- 0
- Sells
- 8
- Bought
- $0
- Sold
- $1.5M
- Companies
- 6
- Companies where not an officer
- 6
- First trade
- 1 Sep 2005
- Last trade
- 4 Jun 2026
- Last filed
- 5 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 4 Jun 2026filed 5 Jun 2026 | PMVP PMV Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —42,000 at $0.00 | filing |
| 4 Jun 2026filed 5 Jun 2026 | PMVP PMV Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —42,000 at $0.00 | filing |
| 5 Jun 2025filed 9 Jun 2025 | PMVP PMV Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —33,500 at $0.00 | filing |
| 6 Jun 2024filed 10 Jun 2024 | PMVP PMV Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —67,500 at $0.00 | filing |
| 8 Jun 2023filed 12 Jun 2023 | PMVP PMV Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —21,500 at $0.00 | filing |
| 7 Jun 2022filed 9 Jun 2022 | MGTX MeiraGTx Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 7 Jun 2022filed 9 Jun 2022 | MGTX MeiraGTx Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 2 Jun 2022filed 6 Jun 2022 | PMVP PMV Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —19,500 at $0.00 | filing |
| 22 Sep 2021filed 23 Sep 2021 | PMVP PMV PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $105K3,500 at $30.00 | filing |
| 23 Aug 2021filed 24 Aug 2021 | PMVP PMV PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $103K3,500 at $29.50 | filing |
| 20 Jul 2021filed 22 Jul 2021 | PMVP PMV PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $123K3,500 at $35.12 | filing |
| 21 Jun 2021filed 22 Jun 2021 | PMVP PMV PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $113K3,389 at $33.22 | filing |
| 21 Jun 2021filed 22 Jun 2021 | PMVP PMV PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $3,784111 at $34.09 | filing |
| 10 Jun 2021filed 14 Jun 2021 | MGTX MeiraGTx Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 10 Jun 2021filed 14 Jun 2021 | MGTX MeiraGTx Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 2 Jun 2021filed 9 Jun 2021 | PMVP PMV Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —16,333 at $0.00 | filing |
| 20 May 2021filed 21 May 2021 | PMVP PMV PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $18K539 at $33.57 | filing |
| 20 May 2021filed 21 May 2021 | PMVP PMV PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $103K2,961 at $34.68 | filing |
| 12 May 2021filed 22 Jul 2021 | PMVP PMV Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —5,781 at $0.00 | filing |
| 2 Jun 2020filed 4 Jun 2020 | MGTX MeiraGTx Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.